Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients.
暂无分享,去创建一个
P. Coulie | C. Doglioni | C. Bordignon | F. Ciceri | C. Traversari | D. Colau | M. Bregni | A. Cipponi | D. Maggioni | R. Fontana | Laura Raccosta | V. Russo | S. Mukenge | F. Lunghi | C. Rainelli